No Role for Reintroducing OPV into the United States with Respect to Controlling COVID‐19 [Response to the letter to the Editor by Chumakov et al.]
Author
Abstract
Suggested Citation
DOI: 10.1111/risa.13671
Download full text from publisher
References listed on IDEAS
- Kimberly M. Thompson & Radboud J. Duintjer Tebbens, 2006. "Retrospective Cost‐Effectiveness Analyses for Polio Vaccination in the United States," Risk Analysis, John Wiley & Sons, vol. 26(6), pages 1423-1440, December.
- Kimberly M. Thompson & John S. Evans, 1997. "The Value of Improved National Exposure Information for Perchloroethylene (Perc): A Case Study for Dry Cleaners," Risk Analysis, John Wiley & Sons, vol. 17(2), pages 253-271, April.
- Radboud J. Duintjer Tebbens & Mark A. Pallansch & Olen M. Kew & Victor M. Cáceres & Hamid Jafari & Stephen L. Cochi & Roland W. Sutter & R. Bruce Aylward & Kimberly M. Thompson, 2006. "Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After Eradication," Risk Analysis, John Wiley & Sons, vol. 26(6), pages 1471-1505, December.
- Esther De Gourville & Radboud J. Duintjer Tebbens & Nalinee Sangrujee & Mark A. Pallansch & Kimberly M. Thompson, 2006. "Global Surveillance and the Value of Information: The Case of the Global Polio Laboratory Network," Risk Analysis, John Wiley & Sons, vol. 26(6), pages 1557-1569, December.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Radboud J. Duintjer Tebbens & Nalinee Sangrujee & Kimberly M. Thompson, 2006. "The Costs of Future Polio Risk Management Policies," Risk Analysis, John Wiley & Sons, vol. 26(6), pages 1507-1531, December.
- Kimberly M. Thompson & Mark A. Pallansch & Radboud J. Duintjer Tebbens & Steve G. Wassilak & Stephen L. Cochi, 2013. "Modeling Population Immunity to Support Efforts to End the Transmission of Live Polioviruses," Risk Analysis, John Wiley & Sons, vol. 33(4), pages 647-663, April.
- Kimberly M. Thompson, 2013. "Modeling Poliovirus Risks and the Legacy of Polio Eradication," Risk Analysis, John Wiley & Sons, vol. 33(4), pages 505-515, April.
- Radboud J. Duintjer Tebbens & Mark A. Pallansch & Olen M. Kew & Roland W. Sutter & R. Bruce Aylward & Margaret Watkins & Howard Gary & James Alexander & Hamid Jafari & Stephen L. Cochi & Kimberly M. T, 2008. "Uncertainty and Sensitivity Analyses of a Decision Analytic Model for Posteradication Polio Risk Management," Risk Analysis, John Wiley & Sons, vol. 28(4), pages 855-876, August.
- Kimberly M. Thompson, 2006. "Poliomyelitis and the Role of Risk Analysis in Global Infectious Disease Policy and Management," Risk Analysis, John Wiley & Sons, vol. 26(6), pages 1419-1421, December.
- Kimberly M. Thompson & Dominika A. Kalkowska, 2021. "Reflections on Modeling Poliovirus Transmission and the Polio Eradication Endgame," Risk Analysis, John Wiley & Sons, vol. 41(2), pages 229-247, February.
- Kimberly M. Thompson & Dominika A. Kalkowska & Kamran Badizadegan, 2021. "A Health Economic Analysis for Oral Poliovirus Vaccine to Prevent COVID‐19 in the United States," Risk Analysis, John Wiley & Sons, vol. 41(2), pages 376-386, February.
- Kimberly M. Thompson & Mark A. Pallansch & Radboud J. Duintjer Tebbens & Steve G. Wassilak & Jong‐Hoon Kim & Stephen L. Cochi, 2013. "Preeradication Vaccine Policy Options for Poliovirus Infection and Disease Control," Risk Analysis, John Wiley & Sons, vol. 33(4), pages 516-543, April.
- Edgar G. Hertwich & Thomas E. McKone & William S. Pease, 1999. "Parameter Uncertainty and Variability In Evaluative Fate and Exposure Models," Risk Analysis, John Wiley & Sons, vol. 19(6), pages 1193-1204, December.
- Sofia Dias & Alex J. Sutton & Nicky J. Welton & A. E. Ades, 2013. "Evidence Synthesis for Decision Making 6," Medical Decision Making, , vol. 33(5), pages 671-678, July.
- Claire McKenna & Karl Claxton, 2011. "Addressing Adoption and Research Design Decisions Simultaneously," Medical Decision Making, , vol. 31(6), pages 853-865, November.
- Stefano Conti & Karl Claxton, 2008. "Dimensions of design space: a decision-theoretic approach to optimal research design," Working Papers 038cherp, Centre for Health Economics, University of York.
- Fumie Yokota & George Gray & James K. Hammitt & Kimberly M. Thompson, 2004. "Tiered Chemical Testing: A Value of Information Approach," Risk Analysis, John Wiley & Sons, vol. 24(6), pages 1625-1639, December.
- Kimberly M. Thompson & Dominika A. Kalkowska, 2021. "An Updated Economic Analysis of the Global Polio Eradication Initiative," Risk Analysis, John Wiley & Sons, vol. 41(2), pages 393-406, February.
- Richard A. Williams & Kimberly M. Thompson, 2004. "Integrated Analysis: Combining Risk and Economic Assessments While Preserving the Separation of Powers," Risk Analysis, John Wiley & Sons, vol. 24(6), pages 1613-1623, December.
- Kimberly M. Thompson & Dominika A. Kalkowska, 2021. "Potential Future Use, Costs, and Value of Poliovirus Vaccines," Risk Analysis, John Wiley & Sons, vol. 41(2), pages 349-363, February.
- Dominika A. Kalkowska & Kimberly M. Thompson, 2021. "Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Borno and Yobe in Northeast Nigeria," Risk Analysis, John Wiley & Sons, vol. 41(2), pages 303-311, February.
- Sung, Hwansoo & Shortle, James S., 2006. "The Expected Value of Sample Information Analysis for Nonpoint Water Quality Management," 2006 Annual meeting, July 23-26, Long Beach, CA 21296, American Agricultural Economics Association (New Name 2008: Agricultural and Applied Economics Association).
- Kamran Badizadegan & Dominika A. Kalkowska & Kimberly M. Thompson, 2023. "Health Economic Analysis of Antiviral Drugs in the Global Polio Eradication Endgame," Medical Decision Making, , vol. 43(7-8), pages 850-862, October.
- A. E. Ades & S. Cliffe, 2002. "Markov Chain Monte Carlo Estimation of a Multiparameter Decision Model: Consistency of Evidence and the Accurate Assessment of Uncertainty," Medical Decision Making, , vol. 22(4), pages 359-371, August.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:riskan:v:41:y:2021:i:2:p:389-392. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: https://doi.org/10.1111/(ISSN)1539-6924 .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.
Printed from https://ideas.repec.org/a/wly/riskan/v41y2021i2p389-392.html